Insider Trading Summary for Alkermes Plc. (ALKS): Year

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
12-Feb-24 10:00 PM View:	08-Feb-24 Payment of Exercise ($2.46M)	Pops Richard F Director and CEO, Alkermes plc Director		Alkermes Plc. - ALKS	12% 1.05M to 1.18M	0	0	--	--	Show Txns Hide Txns

27-Feb-24 4:06 PM View:	23-Feb-24 Payment of Exercise ($53.55K)	Landine Michael J SVP, Corp Dev., Alkermes, Inc.		Alkermes Plc. - ALKS	12% 250.44K to 281.73K	0	0	--	--	Show Txns Hide Txns

01-Jul-24 5:01 PM View:	29-Jun-24 Payment of Exercise ($35.31K)	Snyderman Nancy Lynn Md Director		Alkermes Plc. - ALKS	22% 20.78K to 25.42K	0	0	--	--	Show Txns Hide Txns

01-Jul-24 4:55 PM View:	29-Jun-24 Payment of Exercise ($35.31K)	Gaynor Richard Director		Alkermes Plc. - ALKS	23% 20.36K to 25.0K	0	0	--	--	Show Txns Hide Txns

01-Jul-24 5:02 PM View:	29-Jun-24 Payment of Exercise ($35.31K)	Wilson Frank Anders Director		Alkermes Plc. - ALKS	23% 20.36K to 25.0K	0	0	--	--	Show Txns Hide Txns

27-Feb-24 4:03 PM View:	23-Feb-24 Payment of Exercise ($100.95K)	Hopkinson Craig C. EVP R&D, Chief Medical Officer		Alkermes Plc. - ALKS	94% 56.56K to 109.71K	0	0	--	--	Show Txns Hide Txns

18-Mar-24 4:02 PM View:	18-Mar-24 Private Sale (Planned) ($292.74K)	Nichols Christian Todd SVP, Chief Commercial Officer		Alkermes Plc. - ALKS	54% 42.93K to 65.91K	0	0	--	--	Show Txns Hide Txns

13-Feb-24 5:07 PM View:	10-Feb-24 Payment of Exercise ($29.72K)	Daglio David Angelo Jr. Director		Alkermes Plc. - ALKS	3% 99.7K to 103.14K	0	0	--	--	Show Txns Hide Txns

01-Jul-24 4:59 PM View:	29-Jun-24 Payment of Exercise ($35.31K)	McKeon Brian P Director		Alkermes Plc. - ALKS	27% 29.7K to 37.78K	0	0	--	--	Show Txns Hide Txns

27-Feb-24 4:04 PM View:	23-Feb-24 Payment of Exercise ($114.73K)	Jackson Blair Curtis EVP, Chief Operating Officer		Alkermes Plc. - ALKS	38% 114.12K to 157.8K	0	0	--	--	Show Txns Hide Txns

27-Feb-24 4:08 PM View:	23-Feb-24 Payment of Exercise ($76.50K)	Brown Iain Michael SVP, Chief Financial Officer		Alkermes Plc. - ALKS	40% 82.84K to 116.34K	0	0	--	--	Show Txns Hide Txns

10-Jun-24 8:56 PM View:	09-Jun-24 Payment of Exercise ($22.24K)	Alva Emily Peterson Director		Alkermes Plc. - ALKS	15% 19.72K to 22.66K	0	0	--	--	Show Txns Hide Txns

01-Jul-24 4:58 PM View:	29-Jun-24 Payment of Exercise ($35.31K)	Laurencin Cato T Director		Alkermes Plc. - ALKS	65% 12.01K to 19.81K	0	0	--	--	Show Txns Hide Txns

01-Jul-24 5:04 PM View:	29-Jun-24 Payment of Exercise ($35.31K)	Wright Christopher I Director		Alkermes Plc. - ALKS	98% 7.27K to 14.42K	0	0	--	--	Show Txns Hide Txns

05-Aug-24 4:13 PM View:	03-Aug-24 Payment of Exercise ($24.81K)	Gaffin David Joseph EVP, CLO, Alkermes, Inc.		Alkermes Plc. - ALKS	30% 127.95K to 165.9K	0	0	--	--	Show Txns Hide Txns

27-Feb-24 4:09 PM View:	27-Feb-24 Sale ($8.18K)	Parisi Samuel Joseph VP, Finance (Interim PAO)		Alkermes Plc. - ALKS	98% 3.9K to 7.72K	0	0	--	--	Show Txns Hide Txns

Alkermes Plc. (ALKS)

Last Year

23-Nov-23 -- 22-Nov-24

Company Sentiment

Drug Delivery

Drugs

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades

Buy:	0	--
Sell:	0	--